Literature DB >> 21798383

From SELDI-TOF MS to protein identification by on-chip elution.

Mari Mæland Nilsen1, Kai-Erik Uleberg, Emiel A M Janssen, Jan P A Baak, Odd Ketil Andersen, Anne Hjelle.   

Abstract

SELDI-TOF MS has been demonstrated as a powerful tool for biomarker discovery. However, a major disadvantage of SELDI-TOF MS is the lack of direct identification of the discriminatory peaks discovered. We describe a novel experimental identification strategy where peptides/proteins captured to a weak cation exchange ProteinArray surface (CM10) are eluted, and thereafter identified by utilizing a sensitive LC-MS/MS (i.e. LTQ Orbitrap). A mixture of four known proteins was used to test the novel experimental approach described, and all four proteins were successfully identified. Additionally, a biomarker candidate previously discovered in plasma of Atlantic cod (Gadus morhua) by SELDI-TOF MS was identified. Thus, this study indicated that a combination of on-chip elution and a highly sensitive LC-MS/MS system can be an alternative approach to identify biomarker candidates discovered by use of SELDI-TOF MS.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798383     DOI: 10.1016/j.jprot.2011.06.027

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  3 in total

1.  Biomarkers for Bone Tumors: Discovery from Genomics and Proteomics Studies and Their Challenges.

Authors:  Wan I Wan-Ibrahim; Vivek A Singh; Onn H Hashim; Puteri S Abdul-Rahman
Journal:  Mol Med       Date:  2015-11-13       Impact factor: 6.354

Review 2.  Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases.

Authors:  Shiva Kalantari; Ameneh Jafari; Raheleh Moradpoor; Elmira Ghasemi; Ensieh Khalkhal
Journal:  Int J Proteomics       Date:  2015-11-29

3.  Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis.

Authors:  Ting-Ting Jiang; Li-Ying Shi; Li-Liang Wei; Xiang Li; Su Yang; Chong Wang; Chang-Ming Liu; Zhong-Liang Chen; Hui-Hui Tu; Zhong-Jie Li; Ji-Cheng Li
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.